tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ALX Oncology Reports Q1 2025 Financial Results
PremiumCompany AnnouncementsALX Oncology Reports Q1 2025 Financial Results
2M ago
ALX Oncology reports Q1 EPS (58c) vs (71c) last year
Premium
The Fly
ALX Oncology reports Q1 EPS (58c) vs (71c) last year
2M ago
ALX Oncology price target lowered to $1.20 from $2.20 at UBS
Premium
The Fly
ALX Oncology price target lowered to $1.20 from $2.20 at UBS
3M ago
ALX Oncology price target lowered to $1.50 from $3 at Stifel
PremiumThe FlyALX Oncology price target lowered to $1.50 from $3 at Stifel
4M ago
Promising Developments in ALX Oncology’s Clinical Pipeline Justify Buy Rating
Premium
Ratings
Promising Developments in ALX Oncology’s Clinical Pipeline Justify Buy Rating
4M ago
ALX Oncology Reports 2024 Financial Results and Updates
Premium
Company Announcements
ALX Oncology Reports 2024 Financial Results and Updates
4M ago
ALX Oncology Announces Workforce Reduction and Leadership Change
PremiumCompany AnnouncementsALX Oncology Announces Workforce Reduction and Leadership Change
5M ago
ALX Oncology to introduce new clinical candidate ALX2004
Premium
The Fly
ALX Oncology to introduce new clinical candidate ALX2004
5M ago
ALX Oncology implements strategic prioritization, reduces workforce by 30%
Premium
The Fly
ALX Oncology implements strategic prioritization, reduces workforce by 30%
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100